Chronic Fatigue Syndrome Treatment: What Helps and What Doesn’t

Chronic fatigue syndrome treatment, now usually called ME/CFS treatment, rests on pacing activity within your energy envelope and on treating individual symptoms such as unrefreshing sleep, pain, orthostatic intolerance and brain fog, because no FDA-approved drug treats the disease itself. Graded exercise therapy (GET) is no longer recommended: the CDC removed it from its guidance in 2017, and the UK’s NICE guideline NG206 (2021) advises against exercise programs built on fixed incremental increases.

What Is ME/CFS and How Is It Diagnosed?

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, multi-system disease that causes profound fatigue not explained by other medical conditions. The name “chronic fatigue syndrome” has always been misleading. Calling this disease “chronic fatigue” is like calling emphysema “chronic cough.” The fatigue is real, but it’s one symptom among many [1].

The 2015 Institute of Medicine report proposed renaming the condition Systemic Exertion Intolerance Disease (SEID) and established updated diagnostic criteria. To meet these criteria, a patient needs:

• Substantial reduction in activity level lasting more than 6 months, accompanied by fatigue that is not the result of ongoing exertion and is not substantially relieved by rest
• Post-exertional malaise (PEM): worsening of symptoms after physical, cognitive, or emotional effort
• Unrefreshing sleep: patients wake up feeling as exhausted as when they went to bed
• Plus at least one of: cognitive impairment (“brain fog”) or orthostatic intolerance

These criteria were a major improvement over earlier definitions. They emphasize PEM as a core feature, which matters because it distinguishes ME/CFS from depression, deconditioning, and other fatigue-causing conditions [2].

You will see the illness written several ways: ME/CFS, CFS/ME, ME, CFS or SEID. Older research also uses the Fukuda criteria (1994) and the Canadian Consensus Criteria (2003), while the International Consensus Criteria (2011) by Carruthers and colleagues use the name myalgic encephalomyelitis alone. Our chronic fatigue syndrome condition page covers symptoms and causes in more depth.

Is there a test for chronic fatigue syndrome?

No single blood test or scan confirms ME/CFS. Diagnosis is clinical: a physician takes a careful history focused on PEM, then rules out conditions that cause similar fatigue, such as hypothyroidism, anemia, sleep apnea, celiac disease, autoimmune disease and depression. A normal lab panel does not rule ME/CFS out, which is why many patients hear that their results are fine while they remain very ill.

ME/CFS Treatment Options Compared

ME/CFS treatment is symptom-based, so most patients use several approaches at once. The table below summarizes the options this page covers, the symptom each one targets and how strong the evidence is today. Doses are the ranges described in the sections that follow and are set by a prescribing clinician.

Pacing sits at the top of every current guideline because it addresses PEM, the symptom that drives most relapses. The other rows help specific symptoms and are chosen one at a time, so it is easier to tell what is working.

Pacing: The Energy Envelope

Pacing is the single most important self-management strategy for ME/CFS. The concept is simple: stay within your available energy (“energy envelope”) to avoid triggering post-exertional malaise. In practice, this is harder than it sounds.

Think of your daily energy as a bank account with a fixed balance. Every activity, whether physical, cognitive, or emotional, is a withdrawal. If you overdraw, you don’t just feel tired that evening. You crash 12-72 hours later, sometimes for days or weeks. The crash isn’t proportional to how much you overdid it. A small overdraft can trigger a severe relapse [3].

Practical Pacing Strategies

• Activity tracking: Use a diary or app to log activities and energy levels. Over 2-3 weeks, patterns emerge showing your actual limits versus what you think you can do.
• Pre-emptive rest: Rest before you feel tired, not after. If you wait until exhaustion hits, you’ve already overdone it.
• Breaking tasks into segments: 10 minutes of activity followed by 10 minutes of rest is more sustainable than 30 minutes straight.
• Heart rate monitoring: Some patients use heart rate monitors to stay below their anaerobic threshold (roughly 55-60% of age-predicted max). Going above this threshold appears to trigger PEM more reliably than subjective effort ratings.
• Cognitive pacing: Mental effort drains energy too. Reading, screen time, conversations, and decision-making all count.

A consensus document on pacing by Goudsmit, Nijs, Jason and Wallman, published in Disability and Rehabilitation, describes pacing as a strategy that helps patients avoid the boom-and-bust pattern of overactivity followed by crashes, and recommends that activity levels be set by the patient’s own symptoms rather than by a fixed schedule [4].

How long does it take for pacing to help?

Pacing is a long-term management strategy, not a quick fix. Most patients need several weeks of tracking before they can see their real baseline, and the first goal is fewer and milder crashes rather than more activity. Once crashes become less frequent, some people can carefully expand activity in small, symptom-led steps, while others find their envelope stays narrow for years.

Why Graded Exercise Therapy Fell Out of Favor

For years, the standard recommendation for ME/CFS was graded exercise therapy (GET), a program of gradually increasing physical activity. This was based largely on the 2011 PACE trial, which claimed that GET and cognitive behavioral therapy (CBT) could lead to recovery in a significant proportion of patients.

The PACE trial has since become one of the most controversial studies in modern medicine. Independent reanalysis of the data revealed serious methodological problems:

• The researchers changed their outcome measures mid-trial, loosening recovery criteria so much that patients could be counted as “recovered” while still meeting the entry criteria for being sick
• The study was unblinded (patients knew which treatment they were getting), which inflates subjective outcomes
• When the original, pre-specified outcomes were applied to the data, the benefits of GET essentially disappeared
• Patient surveys consistently report that GET made a majority of participants worse, not better [5]

In 2021, the UK’s National Institute for Health and Care Excellence (NICE) released updated guidelines removing GET as a recommended treatment for ME/CFS. The guidelines explicitly state that physical activity programs based on fixed incremental increases should not be offered. This was a major reversal. The US Centers for Disease Control (CDC) had already removed GET from its recommendations in 2017 [6].

This doesn’t mean all movement is harmful. Gentle, symptom-contingent activity within the energy envelope can help maintain function. The key difference is that the patient controls the pace, not a predetermined schedule.

The full text of NICE guideline NG206 on ME/CFS diagnosis and management also recommends that any physical activity plan be overseen by a physiotherapist or occupational therapist with ME/CFS training, start from the person’s current baseline and be paused or reduced when symptoms worsen.

Sleep: More Than Sleep Hygiene

Unrefreshing sleep is nearly universal in ME/CFS. Patients may sleep 8-10 hours and wake up feeling like they didn’t sleep at all. Standard sleep hygiene advice (consistent bedtime, dark room, no screens) is worth implementing, but it’s rarely sufficient.

Sleep studies in ME/CFS patients often show disrupted sleep architecture: reduced slow-wave sleep, increased alpha-wave intrusion during deep sleep, and fragmented REM cycles. The brain isn’t cycling through restorative sleep stages properly [7].

A sleep study is also worth asking for because treatable sleep disorders, such as obstructive sleep apnea and restless legs syndrome, can sit alongside ME/CFS and add to daytime exhaustion. Treating them will not resolve ME/CFS, but it removes one source of unrefreshing sleep.

Medications That May Help Sleep

• Low-dose trazodone (25-50 mg): Improves sleep quality without the dependency risk of benzodiazepines
• Low-dose amitriptyline (5-20 mg): Can improve sleep and reduce pain, though anticholinergic side effects are common at higher doses
• Suvorexant: An orexin receptor antagonist that may help with sleep maintenance
• Melatonin (0.5-3 mg): Some evidence for improving sleep onset, particularly when circadian rhythm is disrupted
• Gabapentin or pregabalin: May improve sleep quality and reduce pain, but can cause daytime sedation

The goal is restorative sleep, not just more hours in bed. If you’re sleeping 10 hours and still waking exhausted, the issue is sleep quality, not sleep quantity.

Managing Pain and Brain Fog

Pain

Widespread pain affects most ME/CFS patients. It overlaps significantly with fibromyalgia, and many patients meet criteria for both conditions. Low-dose naltrexone (LDN) at 1.5-4.5 mg has shown particular promise for both pain and overall function in small studies, working through modulation of microglial activation and endorphin upregulation [8].

Other pain management approaches include:

• Low-dose tricyclic antidepressants (amitriptyline, nortriptyline) for widespread pain
• NSAIDs for acute pain flares, though long-term use carries GI and cardiovascular risks
• Gentle stretching and myofascial release within energy limits
• Heat therapy for muscle pain and stiffness

Because the overlap is so common, the fibromyalgia condition page and our chronic pain treatment guide are useful companions when pain is the symptom limiting you most.

Cognitive Symptoms

Brain fog in ME/CFS involves difficulty with concentration, word-finding, short-term memory, processing speed, and executive function. It tends to worsen during PEM episodes and improve (though rarely resolve) during stable periods.

Management strategies include:

• Cognitive pacing: Limiting mentally demanding tasks and taking breaks
• External supports: Lists, reminders, voice memos, simplified routines
• Timing: Scheduling cognitively demanding tasks during your best hours (many patients have a window of clearer thinking, often late morning)
• Reducing sensory input: Noise, bright lights, and multi-tasking all worsen cognitive symptoms

Orthostatic Intolerance

Up to 90% of ME/CFS patients have some form of orthostatic intolerance, meaning their symptoms worsen when upright and improve when lying down. This includes postural orthostatic tachycardia syndrome (POTS), neurally mediated hypotension, and orthostatic hypotension.

Management includes:

• Increased salt and fluid intake: 2-3 liters of water daily plus 6-10 grams of sodium (medical supervision required)
• Compression garments: Waist-high compression stockings or abdominal binders
• Fludrocortisone: Increases blood volume by promoting sodium retention
• Midodrine: A vasoconstrictor that raises standing blood pressure
• Beta-blockers (low-dose): Particularly propranolol for POTS-related tachycardia
• Ivabradine: Slows heart rate without lowering blood pressure, useful when blood pressure is already low

Orthostatic intolerance is one of the most treatable parts of ME/CFS, and the US ME/CFS Clinician Coalition recommends screening every patient for it with a simple 10-minute stand test or a tilt table test [11]. Our POTS treatment guide covers the same medications from the dysautonomia side.

Medications and Supplements: What Has Evidence

Medications

• Low-dose naltrexone (LDN): 1.5-4.5 mg daily. Multiple small studies show improvements in fatigue severity, pain, and daily function. Works by modulating microglial inflammation in the central nervous system. Generally well-tolerated, with vivid dreams being the most common side effect [8].
• Rintatolimod (Ampligen): An immunomodulator that has shown benefit in clinical trials but remains unapproved by the FDA. Available in some countries and through compassionate use programs.
• Pyridostigmine: An acetylcholinesterase inhibitor showing benefit for orthostatic intolerance and exercise tolerance in preliminary studies.

LDN is the medication patients ask about most. It is a compounded, off label prescription in the US, so it is usually paid for out of pocket, and it cannot be taken with opioid pain medication. The low-dose naltrexone guide covers titration and what to avoid.

Supplements with Some Evidence

• Coenzyme Q10 (200-300 mg/day): Supports mitochondrial energy production. A randomized controlled trial showed improvements in fatigue severity and autonomic function in ME/CFS patients [9].
• D-Ribose (5 g three times daily): A sugar involved in ATP synthesis. A pilot study showed improvements in energy, sleep, mental clarity, and pain in ME/CFS and fibromyalgia patients.
• NADH (10-20 mg/day): A coenzyme involved in cellular energy production. Limited but positive evidence from small trials.
• B12 (methylcobalamin): Some clinicians report benefit with high-dose sublingual or injectable B12, though controlled trial data is limited.
• Magnesium: Often low in ME/CFS patients. Supplementation (200-400 mg/day of glycinate or threonate) may help with muscle pain, sleep, and energy.

Supplements are not regulated by the FDA as drugs, so purity and dose vary between products. Add one at a time and track symptoms for several weeks, which makes it easier to tell what is helping and what is not.

What Doesn’t Work

Several approaches that were once promoted for ME/CFS have been shown to be ineffective or harmful:

• CBT as a disease treatment: Cognitive behavioral therapy can help patients cope with having a chronic illness, but it does not treat the underlying disease. The 2021 NICE guidelines clarified that CBT should only be offered as a supportive therapy for managing symptoms, not as a treatment for ME/CFS itself.
• “Pushing through” or ignoring symptoms: This consistently worsens the condition. The old advice to “just exercise more” has been directly contradicted by current evidence.
• Antidepressants as primary treatment: ME/CFS is not depression. Antidepressants may help specific symptoms (pain, sleep) at low doses, but they do not treat the core disease process.
• Unproven supplements at high prices: Many online programs sell expensive supplement protocols with no clinical evidence behind them. Be skeptical of any program that costs hundreds per month and promises recovery.

“Adrenal fatigue” protocols belong on this list too. The diagnosis is not recognized by endocrinology societies, and treating it with hormones can cause harm.

Do IV Therapy, NAD+ and Hyperbaric Oxygen Help ME/CFS?

IV therapy, NAD+ infusions and hyperbaric oxygen therapy (HBOT) are offered for fatigue by many cash pay clinics, but none of them is an established ME/CFS treatment. No large controlled trial has tested vitamin drips or NAD+ infusions in people who meet ME/CFS criteria, and HBOT research in this area is limited to small studies, much of it in post-COVID fatigue rather than ME/CFS.

Saline infusions are the exception with a clinical rationale: some physicians use them for severe orthostatic intolerance, because low blood volume is common in ME/CFS. A vitamin or NAD+ drip is a different thing, usually off label, and the travel and time in the chair can themselves trigger PEM in people with a narrow energy envelope.

Questions to ask a clinic before you start

1. Which symptom is this treatment meant to change, and how will you measure it?
2. What evidence in ME/CFS or a closely related condition supports it?
3. How will you adjust the visit schedule to avoid post-exertional crashes?
4. Who supervises the infusion or chamber session, and what are the risks for me?
5. What is the full out-of-pocket cost, and when will we decide whether to stop?

If you decide to try one of these options, the national IV therapy clinic list and the hyperbaric oxygen therapy clinics directory show who offers them, and our guides to NAD+ IV therapy and how hyperbaric oxygen works explain what each involves.

Emerging Research

The scientific understanding of ME/CFS has accelerated in recent years, partly driven by the overlap with long COVID. Key areas of research include:

• Mitochondrial dysfunction: Studies show impaired cellular energy production in ME/CFS patients. Mitochondria in these patients don’t generate ATP efficiently, which may explain both the fatigue and the post-exertional crashes [10].
• Neuroinflammation: PET imaging studies have found elevated markers of neuroinflammation in ME/CFS patients, particularly in the brainstem, thalamus, and limbic system.
• Autoimmunity: Some research suggests autoantibodies against G-protein coupled receptors may play a role. Pilot studies of immunoadsorption (removing these antibodies from the blood) have shown promising results.
• Metabolomics: Blood metabolite profiles in ME/CFS patients are distinct from healthy controls. These metabolic signatures may eventually lead to diagnostic biomarkers and targeted treatments.
• Viral persistence: Evidence of persistent viral reservoirs (particularly EBV and HHV-6) in some patients may explain why antiviral treatments help a subset of patients.

Researchers estimate that a large share of people with long COVID also meet ME/CFS criteria, so results from long COVID trials increasingly inform ME/CFS care. The long COVID fatigue guide covers that overlap, and the National Institutes of Health lists open ME/CFS studies on ClinicalTrials.gov.

Building a Care Team

ME/CFS is best managed by a team that understands the condition. Unfortunately, many doctors still have limited training in ME/CFS. Look for:

• A primary care doctor willing to learn about ME/CFS if they don’t already have experience with it
• A sleep specialist to address sleep architecture problems
• A cardiologist or neurologist familiar with dysautonomia for orthostatic intolerance
• An occupational therapist who understands energy management and pacing
• A psychologist or therapist for coping support (not as a treatment for ME/CFS itself, but for the grief and adjustment that come with chronic illness)

The ME/CFS Clinician Coalition provides free clinical guidance for healthcare providers. Bringing these resources to appointments can help bridge the knowledge gap.

Finding clinics through Regenerated.com

Our chronic fatigue syndrome treatment guide summarizes the options above and links to clinics that list ME/CFS care. Many of these are functional or integrative practices offering cash pay services, so ask the same evidence and pacing questions you would ask any new provider. Listing order on Regenerated.com is not paid ranking, Featured slots are clearly labeled and capped, Verified means a clinic has completed credential checks rather than paid for placement, and the directory is free for patients. Being listed is not an endorsement; the guide to Featured, Verified and organic listings explains each label.

The Bottom Line

ME/CFS is a real, biological disease that requires real medical treatment. The field has moved past the era of “it’s all in your head” and into a period of serious scientific investigation. While no approved treatment yet targets the underlying disease, the combination of pacing, symptom-targeted medications, and mitochondrial support can meaningfully improve quality of life. Stay informed about research developments, because the next few years are likely to bring the first disease-modifying treatments to clinical practice.

Frequently asked questions

What is the best treatment for chronic fatigue syndrome?

Pacing is the most widely recommended treatment for chronic fatigue syndrome, because it reduces post-exertional malaise, the crash that drives most relapses. Current guidance from NICE (2021) and the CDC pairs pacing with treatment of individual symptoms: low-dose medications for unrefreshing sleep and pain, fluids, salt and compression for orthostatic intolerance, and off label options such as low-dose naltrexone. No FDA-approved drug treats ME/CFS itself, so care is built around the symptoms each person has.

Can chronic fatigue syndrome go away?

Some people with ME/CFS improve over time, especially those diagnosed early and those who pace carefully, but full recovery in adults is uncommon and the course varies widely. Many patients have periods of relative stability broken by relapses after infections, stress or overexertion. Because outcomes differ so much, the realistic goal for most people is fewer crashes and better daily function, with treatment adjusted as symptoms change rather than tied to a fixed recovery timeline.

Is graded exercise therapy still recommended for ME/CFS?

Graded exercise therapy is no longer recommended for ME/CFS. NICE guideline NG206 (2021) states that exercise programs based on fixed incremental increases should not be offered, and the CDC removed GET from its guidance in 2017. Patient surveys report that GET left many participants worse. Gentle movement is still reasonable when it stays within the energy envelope, is guided by symptoms and is supervised by a therapist who understands post-exertional malaise.

Does low-dose naltrexone help chronic fatigue syndrome?

Low-dose naltrexone (LDN) helps some people with ME/CFS, mainly with pain, fatigue and daily function, but the evidence comes from small studies rather than large randomized trials in ME/CFS. It is prescribed off label at 1.5 to 4.5 mg daily, usually starting low and increasing slowly, and vivid dreams are the most common side effect. Because naltrexone blocks opioid receptors, it is not combined with opioid pain medication.

What kind of doctor treats chronic fatigue syndrome?

Most people with ME/CFS are diagnosed and managed by a primary care physician or internist, with specialists added for specific symptoms. Cardiologists and neurologists who understand dysautonomia treat orthostatic intolerance and POTS, sleep specialists address unrefreshing sleep, and occupational therapists and physiotherapists help with pacing. Few US physicians specialize in ME/CFS, so the US ME/CFS Clinician Coalition publishes free guidance that patients can bring to appointments.

Is IV therapy good for chronic fatigue?

IV therapy is not an established treatment for ME/CFS. Saline infusions are sometimes used by physicians for severe orthostatic intolerance, but vitamin drips, NAD+ infusions and similar cash pay protocols have not been tested in controlled ME/CFS trials. Some patients report feeling better after IV fluids, which may reflect better hydration in people with low blood volume. Ask any clinic what it expects to change, how it will measure that, and how it will avoid triggering a crash.

Related Reading

• Fatigue and Recovery: The Evidence-Based Guide (Pillar)
• Post-Viral Fatigue: When Tiredness After Illness Won’t Go Away
• Adrenal Fatigue: Why the Diagnosis Is Controversial and What to Do Instead
• Dysautonomia Symptoms: Recognizing Autonomic Nervous System Dysfunction
• EDS and POTS: The Connection Between Hypermobility and Dysautonomia

Sources

1. Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Washington, DC: National Academies Press; 2015. doi:10.17226/19012 ↩
2. Carruthers BM, van de Sande MI, De Meirleir KL, et al. Myalgic encephalomyelitis: international consensus criteria. J Intern Med. 2011;270(4):327-338. doi:10.1111/j.1365-2796.2011.02428.x ↩
3. Jason LA, Brown M, Brown A, et al. Energy conservation/envelope theory interventions to help patients with myalgic encephalomyelitis/chronic fatigue syndrome. Fatigue. 2013;1(1-2):65-78. doi:10.1080/21641846.2012.733602 ↩
4. Goudsmit EM, Nijs J, Jason LA, Wallman KE. Pacing as a strategy to improve energy management in myalgic encephalomyelitis/chronic fatigue syndrome: a consensus document. Disabil Rehabil. 2012;34(13):1140-1147. doi:10.3109/09638288.2011.635746 ↩
5. Wilshire CE, Kindlon T, Courtney R, et al. Rethinking the treatment of chronic fatigue syndrome: a reanalysis and evaluation of findings from a recent major trial of graded exercise and CBT. BMC Psychol. 2018;6(1):6. doi:10.1186/s40359-018-0218-3 ↩
6. National Institute for Health and Care Excellence. Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management. NICE guideline NG206. 2021. ↩
7. Jackson ML, Bruck D. Sleep abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: a review. J Clin Sleep Med. 2012;8(6):719-728. doi:10.5664/jcsm.2276 ↩
8. Younger J, Parkitny L, McLain D. The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. Clin Rheumatol. 2014;33(4):451-459. doi:10.1007/s10067-014-2517-2 ↩
9. Castro-Marrero J, Cordero MD, Segundo MJ, et al. Does oral coenzyme Q10 plus NADH supplementation improve fatigue and biochemical parameters in chronic fatigue syndrome? Antioxid Redox Signal. 2015;22(8):679-685. doi:10.1089/ars.2014.6181 ↩
10. Tomas C, Brown A, Strassheim V, et al. Cellular bioenergetics is impaired in patients with chronic fatigue syndrome. PLoS One. 2017;12(10):e0186802. doi:10.1371/journal.pone.0186802 ↩
11. Bateman L, Bested AC, Bonilla HF, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: essentials of diagnosis and management. Mayo Clin Proc. 2021;96(11):2861-2878. doi:10.1016/j.mayocp.2021.07.004 ↩